Single Rising Dose Study of BI 690517 in Healthy Volunteers
NCT02891148
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
50
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
Interventions
DRUG:
BI 690517
Sponsor
Boehringer Ingelheim